Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

ECOR

ElectroCore Inc

Apr 26 • 04:00PM ET

5.76

Dollar change +0.11
Percentage change 1.95	%

Healthcare • Medical Devices • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-3.56	Insider Own	16.52%	Shs Outstand	6.00M	Perf Week	1.95%
Market Cap	34.56M	Forward P/E	-	EPS next Y	-1.00	Insider Trans	0.00%	Shs Float	5.01M	Perf Month	-1.87%
Income	-18.83M	PEG	-	EPS next Q	-0.59	Inst Own	16.40%	Short Float	0.18%	Perf Quarter	-22.58%
Sales	16.03M	P/S	2.16	EPS this Y	47.19%	Inst Trans	-11.62%	Short Ratio	0.87	Perf Half Y	0.52%
Book/sh	1.24	P/B	4.65	EPS next Y	44.35%	ROA	-90.88%	Short Interest	0.01M	Perf Year	-13.90%
Cash/sh	1.76	P/C	3.27	EPS next 5Y	-	ROE	-153.57%	52W Range	3.83 - 8.08	Perf YTD	-3.22%
Dividend Est.	-	P/FCF	-	EPS past 5Y	28.11%	ROI	-236.04%	52W High	-28.71%	Beta	0.94
Dividend TTM	-	Quick Ratio	1.49	Sales past 5Y	77.42%	Gross Margin	82.51%	52W Low	50.45%	ATR (14)	0.40
Dividend Ex-Date	-	Current Ratio	1.76	EPS Y/Y TTM	24.11%	Oper. Margin	-117.50%	RSI (14)	45.12	Volatility	6.79% 7.02%
Employees	68	Debt/Eq	0.08	Sales Y/Y TTM	86.57%	Profit Margin	-117.49%	Recom	1.00	Target Price	23.10
Option/Short	No / Yes	LT Debt/Eq	0.07	EPS Q/Q	50.07%	Payout	-	Rel Volume	1.67	Prev Close	5.65
Sales Surprise	3.14%	EPS Surprise	-3.04%	Sales Q/Q	102.77%	Earnings	Mar 13 AMC	Avg Volume	10.16K	Price	5.76
SMA20	-1.45%	SMA50	-9.12%	SMA200	-1.95%	Trades		Volume	17,007	Change	1.95%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-14-20	Upgrade	BTIG Research	Neutral → Buy	$3.50
Nov-14-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
Sep-26-19	Resumed	Cantor Fitzgerald	Neutral	$9
May-30-19	Downgrade	Cantor Fitzgerald	Overweight → Neutral
May-15-19	Downgrade	BTIG Research	Buy → Neutral
May-09-19	Initiated	Noble Capital Markets	Outperform
Sep-21-18	Initiated	Cantor Fitzgerald	Overweight

Apr-08-24 08:30AM	electroCore Announces the Launch of Truvaga Plus for General Wellness (GlobeNewswire)
Apr-02-24 08:00AM	electroCore Expands Intellectual Property Portfolio (GlobeNewswire)
Mar-16-24 02:15PM	electroCore, Inc. (NASDAQ:ECOR) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-14-24 06:19AM	Q4 2023 electroCore, Inc. Earnings Call (Thomson Reuters StreetEvents) -5.58%
Mar-13-24 05:25PM	ElectroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	electroCore Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-12-24 08:00AM	electroCore to Participate in Upcoming Investor Conferences (GlobeNewswire) -6.05%
Mar-05-24 04:05PM	electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-06-24 08:00AM	electroCore Expands Intellectual Property Portfolio (GlobeNewswire)
Jan-09-24 08:00AM	electroCore Expands Intellectual Property Portfolio (GlobeNewswire)
Dec-26-23 08:00AM	electroCore Expands Intellectual Property Portfolio (GlobeNewswire)
Dec-21-23 04:13PM	These Stocks under $10 Are Poised To Explode (Insider Monkey)
Dec-12-23 08:00AM	electroCore Expands Intellectual Property Portfolio for Nerve Stimulation Technology (GlobeNewswire)
Nov-15-23 08:15AM	Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023 (GlobeNewswire) +7.80%
Nov-09-23 01:17PM	electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript (Insider Monkey)
06:29PM	Loading…
Nov-08-23 06:29PM	electroCore Inc (ECOR) Reports Substantial Sales Growth in Q3 2023 (GuruFocus.com)
04:01PM	electroCore Announces Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-07-23 08:00AM	electroCore to Participate in Canaccord Genuity's MedTech, Diagnostics and Digital Health & Services Forum (GlobeNewswire) -6.20%
Oct-24-23 08:00AM	Data Highlighting Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Symptoms of Gastroparesis Presented at 2023 American College of Gastroenterology Annual Meeting (GlobeNewswire)
Oct-17-23 08:00AM	electroCore Announces Two-Year Extension of gammaCore Device Listing in the NHS Supply Chain Catalogue (GlobeNewswire)
Oct-11-23 08:00AM	electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology (GlobeNewswire)
Oct-10-23 08:00AM	Data Highlighting Non-Invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Neurological Injury Presented at 2023 World Stroke Congress (GlobeNewswire) -5.11%
Oct-09-23 08:00AM	electroCore to Announce Third Quarter Financial Results on Wednesday, November 8 (GlobeNewswire)
Oct-05-23 08:00AM	electroCore to Participate in the Lytham Partners Fall 2023 Virtual Investor Conference (GlobeNewswire)
Sep-27-23 08:00AM	gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD) (GlobeNewswire)
Sep-26-23 08:00AM	electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology (GlobeNewswire)
Sep-25-23 08:30AM	iAccess Alpha Best Ideas from the Buyside Virtual Conference - Sep 26th-27th 2023 (ACCESSWIRE)
08:00AM	electroCore to Participate in the LD Micro Main Event XVI Conference (GlobeNewswire)
Sep-21-23 08:00AM	electroCore to Present at iAccess Alphas Top 10 Best Ideas from the Buyside Virtual Conference (GlobeNewswire)
Sep-07-23 08:00AM	electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
08:00AM	Loading…
Aug-23-23 08:00AM	electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering (GlobeNewswire)
Aug-11-23 01:41PM	electroCore, Inc. (NASDAQ:ECOR) Q2 2023 Earnings Call Transcript (Insider Monkey)
06:46AM	ECOR: 2Q:23 Revenues Impress (Zacks)
Aug-10-23 07:39AM	Q2 2023 electroCore, Inc. Earnings Call (Thomson Reuters StreetEvents) -8.84%
Aug-09-23 04:05PM	electroCore Announces Second Quarter 2023 Financial Results (GlobeNewswire) -10.10%
Aug-04-23 07:14AM	Daily Vickers Top Buyers & Sellers for 08/04/2023 (Argus Research)
Aug-01-23 08:00AM	electroCore to Announce Second Quarter Financial Results on Wednesday, August 9 (GlobeNewswire)
Jul-31-23 09:29AM	electroCore, Inc. Announces $8.145 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules (GlobeNewswire)
Jul-25-23 08:00AM	gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) Improves Attention and Memory in Patients with Posttraumatic Stress Disorder (PTSD) (GlobeNewswire) -7.20%
Jul-18-23 08:00AM	electroCore Expands Intellectual Patent Portfolio for nVNS Technology (GlobeNewswire)
Jul-17-23 06:03AM	ECOR: Adding Reliefband to the Portfolio (Zacks Small Cap Research)
Jul-13-23 08:00AM	electroCore, Inc. Announces Distribution Agreement with Reliefband Technologies, LLC (GlobeNewswire)
Jul-11-23 08:00AM	electroCore Provides Select Second Quarter 2023 Financial Guidance (GlobeNewswire)
Jul-06-23 08:00AM	gammaCore Non-Invasive Vagal Nerve Stimulation Selected for Study Funded by the National Football League (NFL) and National Football League Players Association (NFLPA) on Alleviating Concussion Symptoms (GlobeNewswire) +6.35%
Jun-27-23 08:00AM	TAC-STIM Non-Invasive Vagal Nerve Stimulation Selected for Inclusion in the Air Force Research Laboratories Real-Time Assessing and Augmenting Cognitive Performance in Extreme Environments Project (GlobeNewswire)
Jun-14-23 08:00AM	electroCore to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC (GlobeNewswire)
Jun-13-23 08:00AM	electroCore Announces Poster to be Presented at the American Headache Societys 65th Annual Scientific Meeting (GlobeNewswire) +7.77%
May-26-23 04:01PM	electroCore, Inc. Announces Departure of JP Errico from the Board of Directors (GlobeNewswire) -5.53%
May-23-23 08:00AM	electroCore to Participate at 13th Annual LD Micro Invitational XIII (GlobeNewswire)
May-04-23 06:33AM	ECOR: Getting A BOOST from New Initiatives (Zacks Small Cap Research) -5.00%
May-03-23 04:01PM	electroCore Announces First Quarter 2023 Financial Results (GlobeNewswire)
May-01-23 04:01PM	electroCore to Participate at Annual Aegis Virtual Conference (GlobeNewswire)
Apr-26-23 08:00AM	National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore (nVNS) in Patients with Opioid Use Disorders (GlobeNewswire)
Apr-24-23 08:00AM	Study Presented at 75th Annual Meeting of the American Academy of Neurology Demonstrates that gammaCore (nVNS) Can Accelerate Foreign Language Learning (GlobeNewswire)
Apr-19-23 08:00AM	electroCore to Announce First Quarter Financial Results on Wednesday, May 3 (GlobeNewswire)
Apr-17-23 08:00AM	electroCore Provides Select First Quarter 2023 Financial Guidance (GlobeNewswire) +9.51%
Apr-12-23 08:00AM	electroCore Expands Intellectual Patent Portfolio for nVNS Technology (GlobeNewswire)
Apr-11-23 08:00AM	electroCore Announces Remittance of Annual License Fee from Teijin for Certain Exclusive Rights in Japan (GlobeNewswire)
Apr-06-23 08:00AM	electroCore, Inc. Announces Product Registration in Indonesia, Malaysia and South Africa (GlobeNewswire)
Apr-04-23 08:00AM	electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through the Carrick Institute (GlobeNewswire)
Mar-23-23 08:00AM	electroCore Reports Results of Pre-Clinical Trial in a Model of Traumatic Brain Injury (GlobeNewswire) +17.10%
Mar-21-23 08:00AM	electroCore's Truvaga Users Reported Improved Stress, Anxiety, Sleep, Energy and Mood in Recent Focus Group Study (GlobeNewswire) +6.46%
Mar-14-23 08:30AM	electroCore Affirms No Direct Exposure to Silicon Valley Bank, Silvergate Bank, or Signature Bank (GlobeNewswire)
Mar-13-23 08:00AM	electroCore Announces Poster to be Presented at the 2023 American Academy of Neurology Annual Scientific Meeting (GlobeNewswire)
Mar-10-23 02:25AM	electroCore, Inc. (NASDAQ:ECOR) Q4 2022 Earnings Call Transcript (Insider Monkey) -5.76%
Mar-09-23 11:48AM	ECOR: 2023 Guidance Propelled by New Products (Zacks Small Cap Research) +9.47%
08:00AM	electroCore to Participate at 35th Annual Roth Conference (GlobeNewswire)
Mar-08-23 04:05PM	electroCore Announces Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +6.58%
Mar-07-23 08:00AM	electroCore Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Mar-01-23 08:00AM	electroCore to Announce Fourth Quarter and Year Ended December 31, 2022 Financial Results on Wednesday, March 8 (GlobeNewswire) -6.57%
Feb-21-23 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with Byond Healthcare Pty Ltd, South Africa (GlobeNewswire) -12.03%
Feb-16-23 08:00AM	electroCore Expands Intellectual Patent Portfolio for nVNS Technology (GlobeNewswire)
Feb-15-23 08:00AM	electroCore Completes Sale of New Jersey Tax Benefits (GlobeNewswire)
07:01AM	Daily Vickers Top Insider Picks for 02/15/2023 (Argus Research)
Feb-14-23 10:30AM	electroCore Announces Reverse Stock Split (GlobeNewswire) -19.89%
06:23AM	Daily Vickers Top Insider Picks for 02/14/2023 (Argus Research)
Feb-13-23 07:30AM	Daily Vickers Top Insider Picks for 02/13/2023 (Argus Research)
Feb-10-23 06:42AM	Daily Vickers Top Insider Picks for 02/10/2023 (Argus Research)
Feb-09-23 06:51AM	Daily Vickers Top Insider Picks for 02/09/2023 (Argus Research)
Feb-08-23 06:45AM	Daily Vickers Top Insider Picks for 02/08/2023 (Argus Research)
Feb-07-23 06:46AM	Daily Vickers Top Insider Picks for 02/07/2023 (Argus Research)
Feb-06-23 06:56AM	Daily Vickers Top Insider Picks for 02/06/2023 (Argus Research)
Feb-03-23 06:32AM	Daily Vickers Top Insider Picks for 02/03/2023 (Argus Research)
06:30AM	ECOR: Commercial Strength Drives 4Q (Zacks Small Cap Research)
Feb-02-23 06:43AM	Daily Vickers Top Insider Picks for 02/02/2023 (Argus Research) +6.91%
Feb-01-23 06:14AM	Daily Vickers Top Insider Picks for 02/01/2023 (Argus Research)
Jan-31-23 06:50AM	Daily Vickers Top Insider Picks for 01/31/2023 (Argus Research)
Jan-30-23 06:42AM	Daily Vickers Top Insider Picks for 01/30/2023 (Argus Research)
Jan-27-23 07:00AM	Daily Vickers Top Insider Picks for 01/27/2023 (Argus Research)
Jan-26-23 06:44AM	Daily Vickers Top Insider Picks for 01/26/2023 (Argus Research)
Jan-25-23 06:39AM	Daily Vickers Top Insider Picks for 01/25/2023 (Argus Research)
Jan-24-23 06:48AM	Daily Vickers Top Insider Picks for 01/24/2023 (Argus Research)
Jan-23-23 06:58AM	Daily Vickers Top Insider Picks for 01/23/2023 (Argus Research)
Jan-20-23 06:55AM	Daily Vickers Top Insider Picks for 01/20/2023 (Argus Research)
Jan-19-23 06:43AM	Daily Vickers Top Insider Picks for 01/19/2023 (Argus Research) +5.20%
Jan-18-23 06:28AM	Daily Vickers Top Insider Picks for 01/18/2023 (Argus Research) -8.03%
Jan-17-23 08:00AM	electroCore Announces Expected Record 4Q 2022 Revenue of $2.5M; Provides Business Update (GlobeNewswire) +25.34%
06:27AM	Daily Vickers Top Insider Picks for 01/17/2023 (Argus Research)
Jan-13-23 06:56AM	Daily Vickers Top Insider Picks for 01/13/2023 (Argus Research)
Jan-12-23 06:50AM	Daily Vickers Top Insider Picks for 01/12/2023 (Argus Research) +8.11%

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Goldberger Daniel S	Chief Executive Officer	Sep 15 '23	Buy	5.55	1,500	8,332	136,060	Sep 19 08:30 AM
Goldberger Daniel S	Chief Executive Officer	Aug 02 '23	Buy	4.35	50,991	221,811	84,560	Aug 03 03:31 PM

Open in Screener

KRMD

KORU Medical Systems Inc

Apr 26 • 04:00PM ET

2.19

Dollar change 0.00
Percentage change 0.00	%

Healthcare • Medical Instruments & Supplies • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

KRMD KORU Medical Systems Inc daily Stock Chart

Held by: VTI IWM VXF IWO VTWO IWC VTWG OMFS VTHR DFUS

Index	RUT	P/E	-	EPS (ttm)	-0.30	Insider Own	5.90%	Shs Outstand	45.67M	Perf Week	5.29%
Market Cap	101.99M	Forward P/E	-	EPS next Y	-0.08	Insider Trans	0.00%	Shs Float	43.83M	Perf Month	-3.74%
Income	-13.74M	PEG	-	EPS next Q	-0.04	Inst Own	56.56%	Short Float	2.62%	Perf Quarter	3.79%
Sales	28.52M	P/S	3.58	EPS this Y	-7.69%	Inst Trans	1.09%	Short Ratio	11.81	Perf Half Y	-11.34%
Book/sh	0.45	P/B	4.91	EPS next Y	44.29%	ROA	-38.82%	Short Interest	1.15M	Perf Year	-47.10%
Cash/sh	0.25	P/C	8.88	EPS next 5Y	-	ROE	-53.18%	52W Range	1.98 - 4.48	Perf YTD	-10.79%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-57.24%	52W High	-51.12%	Beta	0.55
Dividend TTM	-	Quick Ratio	3.77	Sales past 5Y	11.20%	Gross Margin	55.54%	52W Low	10.70%	ATR (14)	0.14
Dividend Ex-Date	-	Current Ratio	4.55	EPS Y/Y TTM	-56.39%	Oper. Margin	-36.01%	RSI (14)	49.88	Volatility	5.23% 6.77%
Employees	82	Debt/Eq	0.22	Sales Y/Y TTM	2.23%	Profit Margin	-48.18%	Recom	1.00	Target Price	3.70
Option/Short	Yes / Yes	LT Debt/Eq	0.18	EPS Q/Q	-275.00%	Payout	-	Rel Volume	0.94	Prev Close	2.19
Sales Surprise	3.48%	EPS Surprise	50.00%	Sales Q/Q	-2.16%	Earnings	May 01 AMC	Avg Volume	97.30K	Price	2.19
SMA20	-2.50%	SMA50	0.33%	SMA200	-7.96%	Trades		Volume	91,205	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-07-23	Initiated	Lake Street	Buy	$4
Sep-07-23	Initiated	B. Riley Securities	Buy	$4.50
Nov-10-22	Upgrade	Piper Sandler	Neutral → Overweight	$3 → $3.50
Nov-10-22	Upgrade	Canaccord Genuity	Hold → Buy	$3 → $4
Jan-26-21	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4.50
Jan-26-21	Downgrade	Canaccord Genuity	Buy → Hold	$5
Aug-10-20	Initiated	H.C. Wainwright	Buy	$16
Jul-16-20	Initiated	Canaccord Genuity	Buy	$13
Jun-24-20	Initiated	Piper Sandler	Overweight	$12

Apr-17-24 07:00AM	KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 (Business Wire)
Apr-11-24 04:05PM	KORU Medical Systems Announces Successful Appeal in EU Notified Body Review (Business Wire)
Mar-18-24 05:24PM	KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference (Business Wire) -5.45%
Mar-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance (Business Wire)
Mar-12-24 08:22AM	KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion (Zacks)
04:05PM	Loading…
Mar-11-24 04:05PM	KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic (Business Wire)
Mar-06-24 07:00AM	KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin (Business Wire) +5.39%
Feb-21-24 07:00AM	KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 (Business Wire)
Nov-29-23 07:00AM	KORU Medical Systems to Participate in Piper Sandlers 35th Annual Healthcare Conference (Business Wire)
Nov-28-23 08:00AM	KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 (Business Wire)
Nov-09-23 10:04AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.31%
Nov-08-23 06:11PM	KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook (GuruFocus.com) -5.19%
04:10PM	KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
04:08PM	KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer (Business Wire)
04:05PM	KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
04:05PM	Loading…
Nov-07-23 04:05PM	KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes (Business Wire)
Nov-02-23 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-23 04:05PM	KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 (Business Wire)
Oct-05-23 07:05AM	KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference (Business Wire)
Oct-04-23 04:05PM	KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors (Business Wire)
Sep-15-23 08:05AM	KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase (Business Wire)
Aug-09-23 04:05PM	KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
Aug-08-23 04:05PM	KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference (Business Wire)
Aug-02-23 05:15PM	KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates (Business Wire)
Jul-31-23 04:05PM	KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023 (Business Wire)
Jul-27-23 04:05PM	KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic (Business Wire)
Jul-10-23 07:01AM	KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes (Business Wire)
Jun-27-23 07:05AM	KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer (Business Wire)
May-09-23 03:15PM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-04-23 04:01PM	KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results (Business Wire)
07:01AM	Loading…
Apr-21-23 07:01AM	KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 (Business Wire)
Mar-08-23 04:01PM	KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022 (Business Wire)
Feb-22-23 04:01PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (Business Wire)
Jan-25-23 07:01AM	KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement (Business Wire)
Nov-21-22 07:01AM	KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference (Business Wire)
Nov-10-22 04:01PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire) +16.88%
Nov-09-22 04:01PM	KORU Medical Systems Announces 2022 Third Quarter Financial Results (Business Wire)
Nov-08-22 07:01AM	KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals (Business Wire)
Oct-26-22 04:01PM	KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022 (Business Wire)
Oct-17-22 04:01PM	KORU Medical Systems to Participate in Upcoming Industry Conferences (Business Wire)
Oct-12-22 07:01AM	KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs (Business Wire)
Oct-05-22 07:01AM	KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium (Business Wire)
Aug-08-22 09:50AM	We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate (Simply Wall St.)
Aug-03-22 04:01PM	KORU Medical Systems Announces 2022 Second Quarter Financial Results (Business Wire)
Jul-20-22 04:01PM	KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 (Business Wire)
Jul-05-22 07:08AM	Investors in Repro Med Systems (NASDAQ:KRMD) have made a fantastic return of 483% over the past five years (Simply Wall St.)
May-10-22 01:29PM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
May-04-22 04:01PM	KORU Medical Systems Announces 2022 First Quarter Financial Results (Business Wire) +6.87%
May-02-22 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge® (Business Wire)
Apr-20-22 04:01PM	KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022 (Business Wire)
Apr-18-22 05:00PM	KORU Medical Systems Appoints Brian Case As Chief Technology Officer (Business Wire)
Mar-28-22 04:47PM	Repro Med Systems, Inc. (NASDAQ:KRMD) drops to US$125m and insiders who purchased earlier this year lose another US$38k (Simply Wall St.)
Mar-02-22 04:01PM	KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results (Business Wire)
Feb-23-22 03:00PM	Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-22 12:30AM	CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022 (Business Wire)
Jan-26-22 07:02AM	Those who invested in Repro Med Systems (NASDAQ:KRMD) five years ago are up 523% (Simply Wall St.) +5.11%
Dec-21-21 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs (Business Wire)
Dec-01-21 04:01PM	KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day (Business Wire)
Nov-27-21 08:06AM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
Nov-10-21 04:00PM	KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes (Business Wire)
Nov-09-21 07:00AM	KORU Medical Systems to Participate in Two Upcoming Conferences (Business Wire) -6.04%
Nov-08-21 07:00AM	KORU Medical Announces Collaboration With Gilero to Accelerate Innovation (Business Wire)
Nov-01-21 07:00AM	KORU Medical Expands Senior Team to Accelerate Growth Strategy (Business Wire) +13.25%
Oct-27-21 04:01PM	KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021 (Business Wire)
Oct-26-21 03:02PM	Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline (Zacks)
07:00AM	KORU Medical Appoints Chris Pazdan as Vice President of Quality Assurance and Regulatory Affairs (Business Wire)
Sep-28-21 09:22AM	Multiple insiders bought Repro Med Systems, Inc. (NASDAQ:KRMD) stock earlier this year, a positive sign for shareholders (Simply Wall St.)
Aug-14-21 03:38AM	Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report (Simply Wall St.)
Aug-11-21 04:01PM	KORU Medical Systems Announces 2021 Second Quarter Financial Results (Business Wire)
Aug-09-21 07:00AM	KORU Medical Systems to Participate in Canaccord Genuitys 41st Annual Growth Conference (Business Wire)
Jul-28-21 07:00AM	KORU Medical Systems to Report Second Quarter 2021 Financial Results on August 11, 2021 (Business Wire)
Jul-27-21 03:03PM	Earnings Preview: Repro Med Systems, Inc. (KRMD) Q2 Earnings Expected to Decline (Zacks)
Jul-14-21 04:43AM	Announcing: Repro Med Systems (NASDAQ:KRMD) Stock Soared An Exciting 635% In The Last Five Years (Simply Wall St.)
Jun-28-21 01:05PM	Lifshitz Law Firm, P.C. Announces Investigations of, CleanSpark, Inc. (NasdaqGS: CLSK), The Geo Group, Inc. (NYSE: GEO), Repro Med Systems, Inc. (NasdaqGS: KRMD), and Romeo Power, Inc. (NYSE: RMO) (GlobeNewswire)
May-25-21 02:39PM	KRMD ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of May 25, 2021 in the Class Action Filed on Behalf of Repro Med Systems, Inc. Limited Shareholders (Newsfile)
01:10PM	FINAL DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses to Contact the Firm (ACCESSWIRE)
12:37PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Repro Med Systems, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of May 25, 2021 - KRMD (Newsfile)
11:00AM	Last Chance to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (ACCESSWIRE)
10:49AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
10:15AM	Lawsuits Filed Against KRMD, ARRY and WISH - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)
09:05AM	KRMD FINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Repro Med Systems, Inc. Investors to Secure Counsel Before Important May 25 Deadline KRMD (GlobeNewswire)
08:00AM	Repro-Med Systems, Inc. Technology Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm (GlobeNewswire)
05:55AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of KRMD, FGEN and CCXI (ACCESSWIRE)
01:45AM	SHAREHODLER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD (PR Newswire)
12:40AM	FINAL DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in to Contact the Firm (ACCESSWIRE)
May-24-21 03:20PM	CLASS ACTION UPDATE for KRMD, ACAD and CCIV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders (ACCESSWIRE)
12:30PM	FINAL DEADLINE TUESDAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in to Contact the Firm (ACCESSWIRE)
11:30AM	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems (KRMD) (Business Wire)
10:48AM	DEADLINE TOMORROW: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
10:00AM	Two Days Left to Actively Participate in Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (Newsfile)
07:10AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KRMD, RMO and CCXI (ACCESSWIRE)
06:25AM	LAWSUITS FILED AGAINST KRMD, PCT and DNMR - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)
May-22-21 11:16PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Repro Med Systems, Inc. d/b/a KORU Medical Systems of Class Action Lawsuit and Upcoming Deadline - KRMD (Newsfile)
May-21-21 02:00PM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of KRMD, DOX and EBS (ACCESSWIRE)
12:30PM	FINAL DEADLINE IMMINENT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (ACCESSWIRE)
11:10AM	SHAREHOLDER ALERT: KRMD DDD CCXI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines (ACCESSWIRE)
11:00AM	Last Couple of Days to Actively Participate Repro-Med Systems, Inc. (KRMD) Class Action - Bronstein, Gewirtz & Grossman, LLC (ACCESSWIRE)
11:00AM	DEADLINE ALERT for KRMD, SOS, GOEV, EBON: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders (GlobeNewswire)
10:41AM	TUESDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Repro Med Systems, Inc. d/b/a KORU Medical Systems and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm (Newsfile)
May-20-21 05:05PM	Lawsuits Filed Against KRMD, DDD and UI - Jakubowitz Law Pursues Shareholders Claims (ACCESSWIRE)

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manko Joseph M. Jr.	Director	Dec 13 '23	Buy	2.40	145,833	349,999	7,609,751	Dec 15 04:05 PM
Manko Joseph M. Jr.	Director	Dec 13 '23	Sale	2.40	145,833	349,999	2,198,825	Dec 15 04:05 PM
Manko Joseph M. Jr.	Director	Aug 21 '23	Buy	2.65	10,000	26,466	7,458,434	Aug 22 04:58 PM
Manko Joseph M. Jr.	Director	Aug 18 '23	Buy	2.54	10,000	25,407	7,448,434	Aug 22 04:58 PM
Tharby Linda M	President and CEO	Aug 18 '23	Buy	2.53	5,272	13,336	1,056,676	Aug 24 09:17 AM
CASCELLA ROBERT	Director	Aug 16 '23	Buy	2.61	19,000	49,533	41,478	Aug 17 04:13 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

ECOR

ElectroCore Inc

KRMD

KORU Medical Systems Inc

Upgrade your FINVIZ experience